2.55 mg per day (subcutaneous in this framing), once daily or split as 2.5 mg twice daily
[2] Kraus D, et al
Studies highlight that the peptide helps generate collagen, elastin, and other key proteins that give your skin its structure and strength
Dosing Recommendations While human clinical trial data remains limited, current evidence-based recommendations derived from animal studies and clinical experience suggest: General anti-inflammatory dosing: 200-500 mcg administered subcutaneously once daily or 500-1000 mcg twice weekly Acute injury management: Higher doses (500-1000 mcg) may be used daily initially, with tapering to maintenance doses Route of administration: Both systemic (subcutaneous/intramuscular) and local (perilesional) injections have shown similar efficacy
Tirzepatide is a dual GIP/GLP-1 receptor agonist , meaning it activates two gut hormone receptors that help regulate appetite, digestion, and blood sugar
The Reality Check: What the Hype Gets Wrong The biohacking community loves GHK-Cu right now, and that enthusiasm is outrunning the evidence in a few specific ways